Missed AI stocks? Missed Quantum Computing Stocks? Missed Space stocks? You are literally just in time for the Proteomic Sector stocks which haven’t seen a huge surge yet and I present to you Quantum-Si ($QSI). 2026 is the BIGGEST year for them with Proteus and their PTM coverage game changer.

Right now QSI is trading near its lowest historical range around $1 to $1.20despite carrying a roughly $230 to $240M market cap and holding a strong cash runway projected into 2028, which significantly reduces near-term dilution risk compared to most early-stage biotechs. This price level has acted as a long-term base where buyers consistently step in, and historically QSI has moved quickly into the $2 to $3 range on volume when catalysts hit. The company recently posted roughly 180% year-over-year revenue growth, which is meaningful for a life-science tools company still early in its commercial rollout. That kind of growth, combined with increasing instrument placements, is often what precedes a re-rating once the market starts pricing in future recurring revenue. On the development side, QSI is not another copy-paste biotech. The company is building next-generation protein sequencing platforms with true single-molecule resolution, targeting a proteomics market still dominated by older, indirect techniques. Its Platinum NGPS platform is designed to deliver amino-acid level reads with simpler workflows, and adoption through distribution partners suggests the technology is real and gaining traction. With applications across antibody characterization, biomarker discovery, and precision medicine, QSI is positioned in a massive total addressable market. Don’t forget Proteus, which is the biggest game disruptor to the Proteomic field. At LITERALLY $1.20 right now, the stock still reflects early skepticism rather than the long-term potential of the platform, which is exactly why many see the current price as disconnected from the underlying technology roadmap. Not financial advice. Always do your own research